The population explosion and unintended pregnancies resulting in elective abortions continue to be the major public health issues in spite of availability of current methods of contraception. There is an urgent need for a better method of contraception that is accepted, effective, and available. Various targets are being investigated that can be used for contraception. The gene knockout technology is a powerful approach to identify such novel targets. Using search in the database, at least 93 genes were identified in the literature whose deletion demonstrated an effect on fertility in male mice. However, majority of these knockouts also demonstrated an effect on non-reproductive organs concomitant with an effect on fertility. The knockouts of only a few genes/proteins induced a specific effect on fertility without a serious side effect. The potential role of these novel genes/proteins in contraception/contraceptive vaccine development is discussed.
ABSTRACT
The population explosion and unintended pregnancies resulting in elective abortions continue to be the major public health issues in spite of availability of current methods of contraception. There is an urgent need for a better method of contraception that is accepted, effective, and available. Various targets are being investigated that can be used for contraception. The gene knockout technology is a powerful approach to identify such novel targets. Using search in the database, at least 93 genes were identified in the literature whose deletion demonstrated an effect on fertility in male mice. However, majority of these knockouts also demonstrated an effect on non-reproductive organs concomitant with an effect on fertility. The knockouts of only a few genes/proteins induced a specific effect on fertility without a serious side effect. The potential role of these novel genes/proteins in contraception/contraceptive vaccine development is discussed.
INTRODUCTION
Presently, very few options are available for fertility control. There is a need for more and improved contraceptive options that can be made available and used in both the developed and developing countries. The need for contraception varies for different couples from postponing childbearing, spacing childbirth, limiting family size, to absolute no childbearing. Contraceptive options currently available to women include hormonal contraceptives e.g., birth control pills, contraceptive patch, hormone injections, natural methods such as abstinence, early withdrawal, intrauterine devices (IUDs) such as the copper IUD, the progestin-releasing IUD, vaginal rings, diaphragm/spermicidal combinations, and sterilization (http://www.patientcareonline.com/patcare/article/articleDe tail) (1) . Currently, contraceptive options available for men are: vasectomy, condoms, and withdrawal prior to ejaculation. Vasectomy or male sterilization is the most effective of male contraceptive methods currently available. However, vasectomy is a permanent procedure with low success rate of fertility reversal even after successful surgical re-anastomosis. Therefore, for men who wish to father children at a later time, condoms and withdrawal are the only contraceptive options, which are either not readily acceptable or have high failure rates.
Immunocontraception offers another approach towards contraception for both men and women. Over the last 20 years, a large number of strategies have been employed for the development contraceptive vaccines and a number of antigens have been identified as potential targets for immunocontraception. Research in this area has focused mainly on raising antibodies against gonadotropic hormones such as luteinizing hormone-releasing hormone (LHRH), follicle-stimulating hormone (FSH) and human chorionic gonadotropin (hCG) (2) , their receptors (3); sperm surface antigens such as fertilization antigen-1 (FA-1), sperm protein (SP)-10, sperm protein (SP)-17, and sperm surface PH-20 antigen (4) and epididymal proteins such as rat epididymal glycoprotein DE (5, 6) . Besides the concerns of safety and efficacy, the major problem associated with the development of an effective contraceptive vaccine is variability of immune response against a particular antigen, which will have major effect on the predictability and reliability of the vaccine (7, 8) . Chemical analogs and protein repressors have also been explored to inhibit/block the reproductive cell synthesis, development, maturation and/or function, which can be used to develop novel contraceptive methods (9) .
Various strategies employed for contraceptive development targeting sperm include inhibition of sperm production, disrupting sperm structure and function, interruption of sperm transport and deposition, and prevention of sperm-egg interaction. All these approaches involve identification of the genes and proteins that are involved specifically in these processes. A large number of genes are involved in reproduction. In the past these genes/cDNAs have been identified by using biochemical methods, hybridization technology, and several molecular and immunological approaches. The advent of gene knockout technology represents a very powerful approach to identify testes/sperm-specific genes/proteins that can provide novel targets for contraception. The study of a mutation in a particular gene that leads to an infertility phenotype in the mouse model can be extrapolated to humans and thus could lead to the identification of novel contraceptive targets.
In this article, we will review the information about the genes that have been identified using the geneknockout technology, whose deletion causes an affect on some parameters of fertility. A total of 93 gene-knockouts were found in the literature search carried on January 15, 2005 in NCBI (National Centre for Biotechnology Information) database that affect fertility in male mice (Table 1) .
These genes can be categorized into following four major groups depending upon the fertilization/fertility parameter that is affected after their deletion: 3. DISCUSSION 3.1. Gene-knockouts that cause defect in sperm structure, function, and/or motility
The literature search revealed a total of 21 genes whose disruption can lead to sperm abnormalities and infertility (Table 1) . Some of these genes are discussed below.
Recently, a family of sperm-specific cation channels has been identified, designated as Catsper1, 2, 3, and 4, respectively, which are localized on the principal piece of sperm flagellum and act as regulators of sperm motility (10), (11, 12) . It has been observed that mice with targeted disruption of catsper1 and catsper 2 are infertile due to the failure to acquire hyperactivated motility, which renders the spermatozoa incapable to penetrate the oocyte (10, 11) . The animals are otherwise phenotypically normal and show no other defect.
Another protein, known as A kinase anchoring protein 4 (AKAP4), seems to be a major component of the sperm flagellum. It is a scaffold protein required for the organization and integrity of the fibrous sheath and thus regulates flagellar function. AKAP4 is a testis-specific protein expressed specifically in the spermatids. In sperm cell, AKAP4 binds to the regulatory subunit of protein kinase A (PKA) leading to its compartmentalization thus ensuring the specificity of its function. Targeted deletion of the Akap4 gene in mice results in the male infertile phenotype (13) . Sperm numbers are not reduced but the spermatozoa fail to show progressive motility, rendering the male mice infertile. There was an incomplete development of the fibrous sheath leading to shortening of the flagellum and abnormal tail development, and the animals show no other phenotypic defect.
Casein kinase II (Ck2) is a c-AMP and calciumindependent serine-threonine kinase that has two isoforms Ck2a and Ck2a / encoded by Csnk2a1 and Csnk2a2, respectively. Csnk2a2 is preferentially expressed in the later stages of spermatogenesis. Disruption of Csnk2a2 leads to male infertility due to oligospermia and globozoospermia (14) . Hook1, a cytoskeletal linker protein is predominantly expressed in the haploid male germ cells. Immunohistochemical analysis revealed that Hook1 is responsible for the linkage of the microtubular manchette and the flagellum to cellular structures. Disruption of hook1 gene result in ectopic positioning of microtubular structures within the spermatid leading to abnormal sperm head shape and infertility (15) . Absence of another protein SSTY1, expressed exclusively in spermatids, leads to abnormal sperm development and abnormally-shaped sperm heads and thus infertility (16) .
Epididymis represents an alternative target organ for male contraception. Spermatozoa produced in the seminiferous tubules of the testis are transported to the epididymis via rete-testis where they undergo a maturation process and acquire their capabilities for forward motility and oocyte fertilization at least in the mouse model. Recently, gene knockout strategies have been employed to identify various epididymal proteins such as c-ros (17) and HE6 (18) that can serve as non-testicular target for male contraception. In mice with targeted disruption of c-ros, sperm exhibit severe tail angulation at midpiece-principal piece junction leading to infertility (17) . Mutant mice with deletion of the epididymal receptor HE6 show dysregulation of fluid reabsorption in the efferent ductules, leading to a backup of fluid accumulation in the testis and a subsequent stasis of spermatozoa within the efferent ducts leading to infertility (18).
3.2.
Gene-knockouts that cause defect in spermatogenesis
The process of spermatogenesis involves the development of spermatogonia into spermatocytes, which undergo meiotic divisions to form haploid round spermatids. The round spermatids differentiate into mature spermatozoa in a process known as spermiogenesis. A large number of genes are involved in the process of spermatogenesis and spermiogenesis and these could be potential targets for male contraceptives. A mutation in a gene involved in spermatogenesis can lead to defect in the development of a mature spermatozoon. A total of 47 genes were found in this category ( Table 1 ).
The generation of haploid spermatids from primary spermatocytes involves the meiotic cell division.
Several genes involved in meiotic process have been disrupted in mice leading to infertility. Protein C inhibitor (PCI) is a plasma protein, also present in high concentration in the male reproductive tract. PCI knockout mice exhibit abnormal spermatogenesis and sperm malformation leading to infertility (19) . Defect in several genes leads to an arrest of spermatogenesis at a specific stage of meiosis leading to infertility. In a Sertoli cell specific androgen receptor (AR)-knockout, spermatogenesis was arrested at diplotene stage of meiosis I leading to azoospermia and infertility (20) . Deletion of dmc1 gene leads to an arrest of spermatogenesis in the meiotic prophase (21) . Cpeb (cytoplasmic polyadenylation element binding protein) controls germ cell differentiation by regulating the formation of synaptonemal complex during meiosis I. In cpeb knockout mice, spermatogenesis is arrested at the pachytene stage of meiosis (22) . Another protein HSP70-2 (heat shock protein 70-2) associates with the synaptonemal complex during meiotic prophase and is expressed at high levels exclusively in pachytene spermatocytes. Spermatocytes fail to progress past the metaphase in the mutant mice (23) . Scp 3 (synaptonemal complex protein 3) is a component of the synaptonemal complex and its disruption leads to an arrest of spermatogenesis at the zygotene stage of meiosis 1 and massive apoptotic cell death during meiotic prophase (24) .
Apart from the genes specifically involved in meiosis, mutations in other genes can also lead to spermatogenic arrest. Dazl knockouts are infertile with a spermatogenic arrest. There is almost complete absence of germ cells beyond the spermatogonial stage leading to infertility (25) . Msh4, a member of the mammalian mismatch repair gene family, is expressed predominantly in testis. Mutant mice show abnormal chromosome pairing during the zygotene phase of meiotic prophase 1 leading to the induction of apoptosis in the spermatocytes and infertility (26) . There is a group of proteins involved in cell cycle called cyclins and cyclin-dependent kinases (CDKs), which interact together to regulate cell division and growth. Cyclin A1 encoded by the CcnA1 locus is expressed exclusively in the germ cell lineages of in testis and ovaries. Mice bearing a null mutation for the CcnA1 gene are infertile due to arrest of spermatogenesis prior to the first meiotic division (27) . The mice mutant in Cks2 gene, encoding the mammalian homolog of the yeast Cdk1-binding protein, are infertile due to a block in spermatogenesis at the metaphase of meiosis I. CKS2 has a role in cell cycle regulation. It binds to the catalytic subunit of the cyclin-dependent kinases and is essential for their function (28).
Post-meiotic stages of spermatogenesis represent interesting targets for contraception. A targeted deletion in crem (c-AMP response element modulator) leads to an interruption in spermatogenesis at round spermatid stage (29) , (30) . The transition proteins (TNP1 and TNP2) are involved in the histone displacement and chromatin condensation during spermatid development. Mice with a disruption in Tnp1 gene have increased abnormal head shapes, increased number of decondensed heads and impaired sperm motility (31) . Tnp2 knockout exhibit teratozoospermia and infertility (32) . Absence of Miwi, a cytoplasmic protein specifically expressed in spermatocytes and spermatids, leads to spermatogenic arrest at the beginning of the round spermatid stage (33) . Absence of HR6B, leads to abnormal postmeiotic condensation of spermatid chromatin (34) .
The process of spermiogenesis, transition of round spermatid into elongated spermatid is susceptible to impairment. Absence of TATA-binding protein like factor (TLF) whose physiological function in the mammalian cell is still unknown, leads to a complete arrest in spermiogenesis at the transition from round and elongated spermatids inducing apoptosis of round spermatids at step7 (35).
Gene-knockouts that cause defect in testis development and disrupt endocrine milieu
The function of several differentially expressed genes is necessary for normal sexual differentiation. Although these genes do not represent good contraceptive targets, knockout studies will help in the understanding the process of testis development. A total of 18 genes were identified in this category (Table 1) . DHH (desert hedgehog), expressed in Sertoli cells is one of the signaling molecules that regulate differentiation of peritubular myoid cells and the consequent formation of testis cords (36) . In Dhh null mice, Leydig cells are absent and spatial organization of tubules is severely affected leading to anastomotic tubules and peritubular cellular abnormalities (37, 38) .
Once testis development is initiated, cells in the testis secrete two hormones, testosterone, and antiMullerian hormone that control further sexual development. Testosterone stimulates the development of the male internal duct system (Wolffian ducts), including the epidydimis, seminal vesicles, and vas deferens. Mullerian inhibiting hormone (MIH) inhibits development of female duct structures and causes degeneration of the Mullerian ducts. Mice mutant in Amh gene (anti-Mullerian hormone) (39) or Amhr2 (anti-Mullerian hormone type 2 receptor) (40) develop female reproductive organs, which block sperm transfer into the vaginal tracts of females. Doublesex-and mab-3-related transcription factor 1 (DMRT1) is another gene involved in testis differentiation. In mice, Dmrt1 is expressed in genital ridges of both sexes and then becomes testis-specific at the end of the sexdetermining period. In testis, Dmrt1 is expressed in germ cells and Sertoli cells (41) . Male mutant mice for Dmrt1 are viable but infertile with hypoplastic testes, because of disorganized seminiferous tubules and absence of germ cells. They also show degeneration of interstitial (Leydig) cells with infiltration by macrophages and abnormal sertoli cell morphology (41) .
Cryptochroidism is the most common disorder of sexual development in the newborn leading to infertility (42) . Mutations in the mouse genes, the great (G-protein coupled receptor affecting testicular descent) (43) and Insl3 (insulin-like 3) (44) result in male infertility secondary to cryptochroidism. GREAT protein is a G-protein coupled transmembrane receptor that mediates hormonal signals affecting testicular descent. It is highly expressed in the gubernaculum, the ligament that controls testicular movement during development (43) . Insulin-like hormone 3 is specifically expressed in the Leydig cells of fetal and postnatal testis and is known to stimulate the gubernaculum outgrowth. Mice mutant in Insl3 show failure of gubernaculum development during embryogenesis leading to bilateral cryptochroidism with free moving testes and genital ducts (44).
Gene-knockouts that cause defect in fertilization
A group of at least 5 genes have been delineated using the gene knockout studies, whose disruption leads to neurotransmission defect and male factor abnormality ( Table 1 ). These genes represent excellent contraceptive targets since there is generally no other defect in any other organ associated with them. The production of sperm is normal with no apparent defect in their morphology and motility. NL1, a zinc metallopeptidase, is expressed mainly in the testis as a secretory protein. Mice mutant in Nl1 show highly decreased fertilization rates and perturbed early development of the fertilized eggs (45) . Other genes whose knockouts have been shown to produce sperm with an impaired binding to oocyte zona pellucida are cyritestin (46) , calmegin (47) , and fertilin ß (48) . Cyritestin is a plasma membrane protein localized in the acrosomal region of spermatids and spermatozoa and is involved in spermoocyte membrane adhesion through binding to integrins. Sperm from the mutant mice are unable to bind the zona pellucida (46) . Calmegin is a testis-specific chaperone protein localized in the endoplasmic reticulum. It binds to the nascent polypeptides synthesized during spermatogenesis. Calmegin null mice are infertile even though spermatogenesis is morphologically normal. The sperm from null mice show defective zona-pellucida binding (47) . Fertilin ß is expressed specifically in testis. It is a sperm surface membrane protein that may be involved in sperm-egg plasma membrane adhesion and fusion during fertilization. Mice mutant in fertilin ß show impaired migration of sperm from uterus into oviduct, and defective binding to the oocyte zona pellucida (48).
Gene-knockouts that cause defect in mating behavior
Polyomavirus enhancer activator 3 (PEA3) is a member of the Ets family of transcriptional regulatory proteins. It is a nuclear protein expressed during embryonic development preferentially at sites of epitheliummesenchyma interaction and is widely expressed in various tissues in adults. PEA3 mutant mice are physiologically normal and live a normal life span. Gross and histological analysis of organs from PEA3 null mice reveals no abnormality. Spermatogenesis and spermiogenesis also appear normal. PEA3 mutant males are infertile due to erectile and/or ejaculatory dysfunction (49) . It was observed that null males engage in normal mating behavior, but they do not induce formation of copulatory plug in females after intercourse and as a result sperm are not detected in the uteri of females that had mated with PEA3 null males.
CONCLUSIONS
The utility of a protein as a target for contraception is contingent upon its: (1) tissue-specific expression in testis/sperm with limited to no expression in somatic cells, (2) role in fertility (spermatogenesis/spermiogenesis/sperm function/fertilization/embryonic development), and (3) it should be accessible and amenable for binding with inhibitors/drugs and/or antibodies. Using gene knockout studies in mice, at least a total of 93 genes were identified by literature search in the NCBI database that showed an effect on male fertility. However, most of them demonstrated an effect on other cells/tissues. Knockouts of 46 of these genes specifically affected fertility with a limited deleterious effect on other organs and/or function. These genes /proteins can provide valuable targets for novel contraceptive development. Also, some of the genes/proteins whose knockout show an effect on fertilization in a tissue-specific manner can be used for the development of a contraceptive vaccine for both males and females.
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